Toferer, C; Schwegel, N; Santner, ; Zach, DK; Hoeller, ; Wallner, M; Gollmer, J; Aziz, F; Von Lewinski, D; Kolesnik, E; Ablasser, K; Zirlik, A; Sourij, H; Verheyen, N
Prognostic impact of SGLT2-inhibitor therapy on survival in patients with transthyretin amyloid cardiomyopathy
EUR HEART J. 2024; 45(S1):ehae6662037--ESC Congress; AUG 30-SEP 02, 2024; London, UK.
Doi: 10.1093/eurheartj/ehae666.2037
[Poster]
Web of Science
FullText
FullText_MUG